Ionis Pharmaceuticals
IONS
IONS
362 hedge funds and large institutions have $7.27B invested in Ionis Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 85 funds opening new positions, 108 increasing their positions, 116 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
5% more call options, than puts
Call options by funds: $34.6M | Put options by funds: $32.9M
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
7% less repeat investments, than reductions
Existing positions increased: 108 | Existing positions reduced: 116
Holders
362
Holding in Top 10
6
Calls
$34.6M
Puts
$32.9M
Top Buyers
| 1 | +$145M | |
| 2 | +$58M | |
| 3 | +$41.9M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$41.9M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$25.1M |
Top Sellers
| 1 | -$80.2M | |
| 2 | -$79.7M | |
| 3 | -$70.1M | |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$26.3M |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$23.3M |